Indeed, LGR4 is a regulator of radiosensitivity in cancer, e.g., in prostate cancer cells [35], and the RSPO1–LGR4 axis could be an important protection factor against the radiation effects of mesenchymal bone stem cells [36]. This evidence concerns the gene RSPO1 and prostate cancer.